Sermorelin is a synthetic
Growth Hormone Releasing Hormone (GHRH) analogueused in
endocrinological and biochemical research.
This peptide stimulates in vitro the
release of growth hormone (HGH) by
the pituitary gland via the GHRH receptors, and is widely studied in the context of
cell growth, aging, and metabolic regulation. Sermorelin is produced according to strict laboratory standards and verified
via
High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥ 99%.
Each batch is intended for controlled scientific research.
Key Specifications
| Feature | Value / Explanation |
|---|
| Name | Sermorelin (GHRH 1–29) |
| Molecular Formula | C149H246N44O42S |
| Molecular Weight | ≈ 3357 Da |
| Form | Lyophilisate (dry powder) |
| Purity | ≥ 99% (HPLC tested) |
| Storage Conditions | Store refrigerated, protected from light and moisture |
Research Relevance
- Studied for its role in growth hormone release and pituitary function.
- Important model for research on GHRH receptor activity and endocrine signaling.
- Often combined with peptides such as GHRP-2 or Ipamorelin for comparative laboratory research.